RH

Richard A. Heyman

LI Ligand Pharmaceuticals Incorporated: 16 patents #9 of 191Top 5%
SS Salk Institute For Biological Studies: 11 patents #29 of 521Top 6%
BM Baylor College Of Medicine: 5 patents #52 of 907Top 6%
EI Eisai: 1 patents #611 of 998Top 65%
📍 Encinitas, CA: #96 of 1,440 inventorsTop 7%
🗺 California: #23,010 of 386,348 inventorsTop 6%
Overall (All Time): #175,310 of 4,157,543Top 5%
24
Patents All Time

Issued Patents All Time

Showing 1–24 of 24 patents

Patent #TitleCo-InventorsDate
7655699 Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors Marcus F. Boehm 2010-02-02
7259188 Methods and pharmaceutical compositions for treatment of anti-estrogen resistant breast cancer using RXR modulators William W. Lamph, Eric Bischoff 2007-08-21
7056954 Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor Ronald M. Evans, David J. Mangelsdorf, Marcus F. Boehm, Gregor Eichele, Christina Thaller 2006-06-06
6992108 Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor Ronald M. Evans, David J. Mangelsdorf, Marcus F. Boehm, Gregor Eichele, Christina Thaller 2006-01-31
6677311 Inducible HSV-TK in transformed cell populations Ronald M. Evans, Emiliana Borrelli 2004-01-13
6610883 Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors Marcus F. Boehm, Lin Zhi, Chan-Kou Hwang, Steve White, Alex M. Nadzan 2003-08-26
6576676 Means for the modulation of processes mediated by retinold receptors and compounds useful therefor Ronald M. Evans, David J. Mangelsdorf, Marcus F. Boehm, Gregor Eichele, Christina Thaller 2003-06-10
6545049 Dimer-selective RXR modulators and methods for their use Stacie Canan-Koch, Chan-Kou Hwang, Marcus F. Boehm, Beth Ann Badea, Laura J. Dardashti +5 more 2003-04-08
6521633 Treating NIDDM with RXR agonists Rosemary Cesario, Ranjan Mukherjee 2003-02-18
6506917 Compounds and compositions useful for modulation of processes mediated by RXR Ronald M. Evans, David J. Mangelsdorf, Marcus F. Boehm, Gregor Eichele, Christina Thaller 2003-01-14
6320074 Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors Marcus F. Boehm, Lin Zhi, Stacie Canan Koch 2001-11-20
6316404 Treating NIDDM with RXR agonists Rosemary Cesario, Ranjan Mukherjee 2001-11-13
6228862 Treating NIDDM with RXR agonists Rosemary Cesario, Ranjan Mukherjee 2001-05-08
6096787 Use of selective ligands for treatment of disease states responsive to steroid or steroid-like hormones Ronald M. Evans, Christina S. Berger, Robert B. Stein 2000-08-01
6043279 Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors Marcus F. Boehm 2000-03-28
6028052 Treating NIDDM with RXR agonists Rosemary Cesario, Ranjan Mukherjee 2000-02-22
5990163 Selective modulation of processes mediated by retinoid X receptors, and compounds useful therefor Ronald M. Evans, David J. Mangelsdorf, Marcus F. Boehm, Margaret A. Harmon 1999-11-23
5972881 Treating NIDDM with RXR agonists Rosemary Cesario, Ranjan Mukherjee 1999-10-26
5968989 Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor Ronald M. Evans, David J. Mangelsdorf, Marcus F. Boehm, Gregor Eichele, Christina Thaller 1999-10-19
5962731 Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors Marcus F. Boehm 1999-10-05
5932622 Method for in vivo modulation of non-malignant skin-related processes with 9-cis-retinoic acid Ronald M. Evans, David J. Mangelsdorf, Marcus F. Boehm, Gregor Eichele, Christina Thaller 1999-08-03
5780676 Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors Marcus F. Boehm, Lin Zhi, Chan-Kou Hwang, Steve White, Alex M. Nadzan 1998-07-14
5668175 Use of selective ligands for treatment of disease states responsive to steroid or steroid-like retinoids Ronald M. Evans, Christina S. Berger, Robert B. Stein 1997-09-16
5602009 Dominant negative chimeras of the steroid/thyroid superfamily of receptors Ronald M. Evans, Stanley M. Hollenberg, Anthony E. Oro, Klaus Damm 1997-02-11